MediWound (MDWD) Research & Development (2013 - 2026)
MediWound (MDWD) posted quarterly Research & Development of $4.5 million for Q4 2025, up 49.97% year-over-year from $3.0 million in Q4 2024, and up 29.24% quarter-over-quarter from $3.5 million in Q3 2025.
MediWound (MDWD) Research & Development (2013 - 2026) Analysis & Trends
MediWound's Research & Development history runs 13 years deep, the most recent figure standing at $4.5 million for Q4 2025.
- In Q4 2025, Research & Development rose 49.97% year-over-year to $4.5 million; the TTM figure through Dec 2025 stood at $14.3 million (up 61.3% YoY), while the FY2025 annual figure was $14.3 million, up 61.3% from the prior year.
- Research & Development for Q4 2025 stood at $4.5 million, up from $3.5 million in the prior quarter.
- The five-year high for Research & Development was $4.5 million in Q4 2025, with the low at $1.5 million in Q1 2024.
- The 5-year median for Research & Development is $2.5 million (2021), against an average of $2.6 million.
- The sharpest annual moves came in 2023 and 2025: Research & Development sank 46.83% in 2023, then surged 96.33% in 2025.
- MediWound's Research & Development stood at $2.5 million in 2021, then climbed by 9.67% to $2.7 million in 2022, then slumped by 33.01% to $1.8 million in 2023, then surged by 65.15% to $3.0 million in 2024, then soared by 49.97% to $4.5 million in 2025.
- Business Quant data shows MDWD's Research & Development at $4.5 million in Q4 2025, $3.5 million in Q3 2025, and $3.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.01 Bn | 132.16 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | 1.37 Bn |
| 4 | Moderna | 60.18 Bn | 55.04 Bn | 52.00 Mn | 651.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 612.28 Mn |
| 6 | Alnylam Pharmaceuticals | 31.55 Bn | 28.24 Bn | 992.69 Mn | 413.13 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn | -588.31 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 210.03 Mn |
| 9 | Royalty Pharma | 27.19 Bn | 26.36 Bn | - | 97.90 Mn |
| 10 | MediWound | 168.65 Mn | 137.65 Mn | 337,000.00 | 5.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.90 Mn |
| Dec 31, 2025 | 4.48 Mn |
| Sep 30, 2025 | 3.47 Mn |
| Jun 30, 2025 | 3.49 Mn |
| Mar 31, 2025 | 2.89 Mn |
| Dec 31, 2024 | 2.99 Mn |
| Sep 30, 2024 | 2.52 Mn |
| Jun 30, 2024 | 1.90 Mn |
| Mar 31, 2024 | 1.47 Mn |
| Dec 31, 2023 | 1.81 Mn |
| Sep 30, 2023 | 1.53 Mn |
| Jun 30, 2023 | 2.02 Mn |
| Mar 31, 2023 | 2.10 Mn |
| Dec 31, 2022 | 2.70 Mn |
| Sep 30, 2022 | 2.88 Mn |
| Jun 30, 2022 | 2.19 Mn |
| Mar 31, 2022 | 2.41 Mn |
| Dec 31, 2021 | 2.46 Mn |
| Sep 30, 2021 | 2.90 Mn |
| Jun 30, 2021 | 2.66 Mn |